SWP
GILD icon

Significant Wealth Partners’s Gilead Sciences GILD Stock Holding History

Significant Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Buy
4,083
+9
+0.2% +$1.19K 0.56% 54
2026
Q1 		$568K Buy
4,074
+861
+27% +$121K 0.7% 40
2025
Q4 		$394K Sell
3,213
-3,261
-50% -$396K 0.44% 32
2025
Q3 		$719K Buy
6,474
+713
+12% +$81K 0.35% 27
2025
Q2 		$639K Sell
5,761
-699
-11% -$74.4K 0.31% 23
2025
Q1 		$724K Buy
6,460
+616
+11% +$63.6K 0.37% 13
2024
Q4 		$540K Sell
5,844
-214
-4% -$19.3K 0.28% 22
2024
Q3 		$508K Buy
6,058
+378
+7% +$28.8K 0.26% 24
2024
Q2 		$390K Sell
5,680
-7,216
-56% -$482K 0.22% 30
2024
Q1 		$945K Sell
12,896
-3,804
-23% -$293K 0.62% 47
2023
Q4 		$1.35M Buy
+16,700
New +$1.3M 0.98% 30

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Significant Wealth Partners's GILD Position: Q2 2026 in Review

Significant Wealth Partners increased its Gilead Sciences (GILD) stake by 0.22% in Q2 2026, buying an estimated $1.19K and bringing the position to 4,083 shares worth $516K. The position accounts for 0.56% of the portfolio, ranked #54.

Significant Wealth Partners first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.35M in Q4 2023. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Significant Wealth Partners held 4,083 shares of Gilead Sciences worth $516K as of Q2 2026.
  • Significant Wealth Partners bought 9 Gilead Sciences shares in Q2 2026, an estimated $1.19K.
  • Gilead Sciences made up 0.56% of Significant Wealth Partners's portfolio in Q2 2026, its #54 holding.
  • Significant Wealth Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Significant Wealth Partners's Gilead Sciences position peaked at $1.35M in Q4 2023.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Significant Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.